Bollmann, L.M.; Lange, F.; Hamacher, A.; Biermann, L.; Schäker-Hübner, L.; Hansen, F.K.; Kassack, M.U.
Triple Combination of Entinostat, a Bromodomain Inhibitor, and Cisplatin Is a Promising Treatment Option for Bladder Cancer. Cancers 2024, 16, 3374.
https://doi.org/10.3390/cancers16193374
AMA Style
Bollmann LM, Lange F, Hamacher A, Biermann L, Schäker-Hübner L, Hansen FK, Kassack MU.
Triple Combination of Entinostat, a Bromodomain Inhibitor, and Cisplatin Is a Promising Treatment Option for Bladder Cancer. Cancers. 2024; 16(19):3374.
https://doi.org/10.3390/cancers16193374
Chicago/Turabian Style
Bollmann, Lukas M., Friedrich Lange, Alexandra Hamacher, Lukas Biermann, Linda Schäker-Hübner, Finn K. Hansen, and Matthias U. Kassack.
2024. "Triple Combination of Entinostat, a Bromodomain Inhibitor, and Cisplatin Is a Promising Treatment Option for Bladder Cancer" Cancers 16, no. 19: 3374.
https://doi.org/10.3390/cancers16193374
APA Style
Bollmann, L. M., Lange, F., Hamacher, A., Biermann, L., Schäker-Hübner, L., Hansen, F. K., & Kassack, M. U.
(2024). Triple Combination of Entinostat, a Bromodomain Inhibitor, and Cisplatin Is a Promising Treatment Option for Bladder Cancer. Cancers, 16(19), 3374.
https://doi.org/10.3390/cancers16193374